Suppression of cell transformation by the cyclin-dependent kinase inhibitor pSTKIP2 requires binding to proliferating cell nuclear antigen

Hiroyuki Watanabe, Zhen Qiang Pan, Nicole Schreiber-Agus, Ronald A. DePinho, Jerard Hurwitz, Yue Xiong

Research output: Contribution to journalArticlepeer-review

145 Scopus citations

Fingerprint

Dive into the research topics of 'Suppression of cell transformation by the cyclin-dependent kinase inhibitor pSTKIP2 requires binding to proliferating cell nuclear antigen'. Together they form a unique fingerprint.

Medicine & Life Sciences